Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Evans

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Scientific Reports|April 12, 2016
Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infectionLing Li, Hie-Won Hann, Shaogui Wan, et al.
Cardiovascular Research|November 11, 2010
Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutationsKatja Gehmlich, Petros Syrris, Emma Peskett, et al.
Circulation|January 18, 2006
Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathyPetros Syrris, Deirdre Ward, Angeliki Asimaki, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 30, 2015
The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular CarcinomaMengjun Wang, Karthik Devarajan, Amit G Singal, et al.
Expert Opinion on Drug Safety|July 24, 2020
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practiceLuis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, et al.
Journal of the American College of Cardiology|March 16, 2005
Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural historyRoss T Murphy, Jens Mogensen, Kate McGarry, et al.
NPJ Primary Care Respiratory Medicine|February 23, 2026
Key factors for implementing inhaler regimen switches in respiratory diseases: international expert consensus generated using a modified nominal group technique (NGT)Omar S Usmani, Nicolas Roche, Job F M van Boven, et al.
Lancet (London, England)|April 25, 2015
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trialWillem Kuyken, Rachel Hayes, Barbara Barrett, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.
Journal of Clinical Medicine|September 28, 2023
Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept TrialPratima Chowdary, Banwari Agarwal, Maria Rita Peralta, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Scientific Reports|April 12, 2016
Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infectionLing Li, Hie-Won Hann, Shaogui Wan, et al.
Cardiovascular Research|November 11, 2010
Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutationsKatja Gehmlich, Petros Syrris, Emma Peskett, et al.
Circulation|January 18, 2006
Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathyPetros Syrris, Deirdre Ward, Angeliki Asimaki, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 30, 2015
The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular CarcinomaMengjun Wang, Karthik Devarajan, Amit G Singal, et al.
Expert Opinion on Drug Safety|July 24, 2020
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practiceLuis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, et al.
Journal of the American College of Cardiology|March 16, 2005
Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural historyRoss T Murphy, Jens Mogensen, Kate McGarry, et al.
NPJ Primary Care Respiratory Medicine|February 23, 2026
Key factors for implementing inhaler regimen switches in respiratory diseases: international expert consensus generated using a modified nominal group technique (NGT)Omar S Usmani, Nicolas Roche, Job F M van Boven, et al.
Lancet (London, England)|April 25, 2015
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trialWillem Kuyken, Rachel Hayes, Barbara Barrett, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.
Journal of Clinical Medicine|September 28, 2023
Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept TrialPratima Chowdary, Banwari Agarwal, Maria Rita Peralta, et al.
Pageof 11